Research ExplorerPublicationsFirst experience with a new drug-eluting balloon for the tre...

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate

Standard

First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate. / Mueller, Goetz Christoph; Dodge-Khatami, Ali; Weil, Jochen.

In: CARDIOL YOUNG, Vol. 20, No. 4, 08.2010, p. 455-458.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Mueller, GC, Dodge-Khatami, A & Weil, J 2010, 'First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate', CARDIOL YOUNG, vol. 20, no. 4, pp. 455-458. https://doi.org/10.1017/S1047951110000703

APA

Mueller, G. C., Dodge-Khatami, A., & Weil, J. (2010). First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate. CARDIOL YOUNG, 20(4), 455-458. https://doi.org/10.1017/S1047951110000703

Vancouver

Mueller GC, Dodge-Khatami A, Weil J. First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate. CARDIOL YOUNG. 2010 Aug;20(4):455-458. https://doi.org/10.1017/S1047951110000703

Bibtex

@article{b0a02bcae2b244e29b73eab3788a1087,
title = "First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate",
abstract = "Paclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a high mortality rate due to residual or recurrent stenosis. We report the first case of treatment for neonatal pulmonary vein restenosis with a paclitaxel-eluting balloon.",
keywords = "Age Factors, Catheterization/instrumentation, Drug-Eluting Stents, Humans, Infant, Newborn, Paclitaxel/adverse effects, Pulmonary Valve Stenosis/congenital, Tubulin Modulators/adverse effects",
author = "Mueller, {Goetz Christoph} and Ali Dodge-Khatami and Jochen Weil",
year = "2010",
month = aug,
doi = "10.1017/S1047951110000703",
language = "English",
volume = "20",
pages = "455--458",
journal = "CARDIOL YOUNG",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "4",

}

RIS

TY - JOUR

T1 - First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate

AU - Mueller, Goetz Christoph

AU - Dodge-Khatami, Ali

AU - Weil, Jochen

PY - 2010/8

Y1 - 2010/8

N2 - Paclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a high mortality rate due to residual or recurrent stenosis. We report the first case of treatment for neonatal pulmonary vein restenosis with a paclitaxel-eluting balloon.

AB - Paclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a high mortality rate due to residual or recurrent stenosis. We report the first case of treatment for neonatal pulmonary vein restenosis with a paclitaxel-eluting balloon.

KW - Age Factors

KW - Catheterization/instrumentation

KW - Drug-Eluting Stents

KW - Humans

KW - Infant, Newborn

KW - Paclitaxel/adverse effects

KW - Pulmonary Valve Stenosis/congenital

KW - Tubulin Modulators/adverse effects

U2 - 10.1017/S1047951110000703

DO - 10.1017/S1047951110000703

M3 - SCORING: Journal article

C2 - 20519055

VL - 20

SP - 455

EP - 458

JO - CARDIOL YOUNG

JF - CARDIOL YOUNG

SN - 1047-9511

IS - 4

ER -